TGA Approval

NELARABINE-REACH nelarabine 250 mg/50 mL solution for infusion vial (405072)

ARTG ID

405072

ARTG Name

NELARABINE-REACH nelarabine 250 mg/50 mL solution for infusion vial

Sponsor

Reach Pharmaceuticals Pty Ltd

ARTG Date

April 3, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

REACH PHARMACEUTICALS PTY LTD

https://medical-cdn.nocode.com/drug_tga/cf9e0e438da2624c17139996755fe108.pdf

https://medical-cdn.nocode.com/drug_tga/9abd5fcc86d41b243ab8927b95a8ef45.pdf

Ingredient Name

nelarabine

Empowering clinical research with data-driven insights and AI-powered tools.

NELARABINE-REACH nelarabine 250 mg/50 mL solution for infusion vial (405072) - TGA 批准文号 | MedPath